Setmelanotide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Setmelanotide is FDA-approved (Imcivree) for genetic and acquired hypothalamic obesity. Prescription medication. Regulations vary by country, and the legal landscape for peptides is evolving. This guide covers the current legal status and what researchers need to know.
Is Setmelanotide Legal?
FDA-approved (Imcivree) for genetic and acquired hypothalamic obesity. Prescription medication.
The legal landscape for peptides like Setmelanotide is nuanced and varies by jurisdiction. This guide covers the current regulatory status and what researchers need to know.
What Is the Legal Status of Setmelanotide in the United States?
Setmelanotide is generally available as a research chemical in the US. It is not FDA-approved for human use, which means it cannot be marketed, sold, or prescribed as a drug or supplement.
However, research chemicals can be legally purchased for laboratory, in vitro, or educational use. The key legal distinction is between personal research use and human consumption — the latter is not approved.
Is Setmelanotide Legal Internationally?
Peptide regulations vary significantly by country. Some jurisdictions classify peptides as prescription-only compounds, while others allow research chemical sales similar to the US.
Australia: Most peptides require a prescription. UK: Generally available for research. Canada: Research chemical status. EU: Varies by country. Always check local regulations before purchasing.
Is Setmelanotide Banned in Sports?
Setmelanotide may be subject to anti-doping regulations depending on its class and mechanism. Athletes should check the current WADA prohibited list.
If you compete in any organized sport, assume all peptides are prohibited unless you have confirmed otherwise with your sport's governing body.
How Is the Legal Landscape Changing?
Peptide regulation is an evolving area. The FDA has increased scrutiny of compounding pharmacies and research chemical vendors in recent years. Some peptides that were freely available have faced new restrictions.
Staying informed about regulatory changes is important for researchers working with Setmelanotide and similar compounds.
Bottom Line on Setmelanotide Legality
FDA-approved (Imcivree) for genetic and acquired hypothalamic obesity. Prescription medication. Researchers should ensure compliance with their local laws and use Setmelanotide only for legitimate research purposes.
Complete Guide
Setmelanotide : Benefits, Dosage, Side Effects & Research
Related Reading
- Setmelanotide Dosage Guide
- Setmelanotide Benefits
- Setmelanotide Side Effects
- Setmelanotide Stacking Guide
- Setmelanotide Cycle Guide
- Setmelanotide Research
Calculate Your Setmelanotide Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Setmelanotide.
Open Calculator →Research-Grade Sourcing
If you're going to research Setmelanotide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Setmelanotide?
Setmelanotide (Setmelanotide (MC4R agonist)) is a Melanocortin-4 receptor agonist. Developed by Rhythm Pharmaceuticals as first-in-class MC4R agonist for genetic obesity. It is researched for weight loss in genetic obesity, appetite reduction, energy expenditure increase, BMI reduction.
What is the recommended Setmelanotide dosage?
Common dosages: 1-3 mg daily administered once daily via subcutaneous injection. Cycle length: ongoing continuous therapy. Half-life: not publicly disclosed. Use our peptide calculator for exact reconstitution math.
What are the side effects of Setmelanotide?
Hyperpigmentation (skin, moles, lips) most common — reversible upon discontinuation. Injection site reactions, nausea, headache. Generally well-tolerated.
Is Setmelanotide safe?
Setmelanotide has shown a favorable safety profile in research. FDA-approved (Imcivree) for genetic and acquired hypothalamic obesity. Prescription medication. All research should follow appropriate safety protocols.